Format

Send to

Choose Destination
Ann Hepatol. 2013 Mar-Apr;12(2):183-9.

S-adenosylmethionine metabolism and liver disease.

Author information

1
CIC bioGUNE, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Parque Tecnológico de Bizkaia, 48160 Derio, Bizkaia, Spain. director@cicbiogune.com

Abstract

Methionine is an essential amino acid that is metabolized mainly by the liver where it is converted to S-adenosylmethionine (SAMe) by the enzyme methionine adenosyltransferase. Although all mammalian cells synthesize SAMe, the liver is where the bulk of SAMe is generated as it is the organ where about 50% of all dietary methionine is metabolized. SAMe is mainly needed for methylation of a large variety of substrates (DNA, proteins, lipids and many other small molecules) and polyamine synthesis, so if the concentration of SAMe falls below a certain level or rises too much the normal function of the liver will be also affected. There are physiological conditions that can affect the hepatic content of SAMe. Consequently, to control these fluctuations, the rate at which the liver both synthesizes and catabolizes SAMe is tightly regulated. In mice, failure to do this can lead to fatty liver disease and to the development of hepatocellular carcinoma (HCC). Therefore, maintaining SAMe homeostasis may be a therapeutic target in nonalcoholic steatohepatitis, alcoholic- and non-alcoholic liver cirrhosis, and for the chemoprevention of HCC formation.

PMID:
23396728
PMCID:
PMC4027041
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for IndexCopernicus Icon for PubMed Central
Loading ...
Support Center